Thoracic Cancer : Impact Factor & More
eISSN: 1759-7714pISSN: 1759-7706
Open AccessShare this on:
Key Metrics
CiteScore 
4.2
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.87
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Thoracic Cancer
Thoracic Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Semi-monthly |
| Article Processing Charges | USD 2000 |
| Publication Time | 41 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | China Lung Oncology Group |
| Frequency | Semi-monthly |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Thoracic Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Thoracic Cancer
Overall Survival With Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2\u2010Positive Metastatic Breast Cancer: A Single\u2010Center Pooled Analysis
- 6 Aug 2026
- Thoracic Cancer
Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines
- 4 Aug 2026
- Thoracic Cancer
A Noncanonical MET Exon 14 Splice-Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib.
- 1 Aug 2026
- Thoracic cancer
Title not available
- 1 Aug 2026
- Thoracic Cancer
Advanced Thymoma and Advanced Thymic Carcinoma Treatment Practices in 2018\u20132022: A Nationwide Analysis in Japan
- 31 Jul 2026
- Thoracic Cancer
CtDNA Detection of Polyclonal KRAS Resistance in Adagrasib\u2010Treated NSCLC
- 29 Jul 2026
- Thoracic Cancer
Overall Survival With Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2\u2010Positive Metastatic Breast Cancer: A Single\u2010Center Pooled Analysis
- 6 Aug 2026
- Thoracic Cancer
Insights Into Genomic Drivers, Transcriptomic Heterogeneity, and Therapeutic Vulnerabilities From Novel Mesothelioma Cell Lines
- 4 Aug 2026
- Thoracic Cancer
A Noncanonical MET Exon 14 Splice-Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib.
- 1 Aug 2026
- Thoracic cancer
Title not available
- 1 Aug 2026
- Thoracic Cancer
Advanced Thymoma and Advanced Thymic Carcinoma Treatment Practices in 2018\u20132022: A Nationwide Analysis in Japan
- 31 Jul 2026
- Thoracic Cancer
CtDNA Detection of Polyclonal KRAS Resistance in Adagrasib\u2010Treated NSCLC
- 29 Jul 2026
- Thoracic Cancer
FAQs on Thoracic Cancer
How long has Thoracic Cancer been actively publishing? 
What is the publishing frequency of Thoracic Cancer?
How many articles did Thoracic Cancer publish last year?
What is the eISSN & pISSN for Thoracic Cancer?
What is Citescore for Thoracic Cancer?
What is SNIP score for Thoracic Cancer?
What is the SJR for Thoracic Cancer?
Who is the publisher of Thoracic Cancer?
